Статья
THE PROGNOSTING VALUE OF COMBING NEW BIOMARKERS FOR REMOTE CARDIOVASCULAR ENDPOINTS RISK STRATIFICATION IN PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION
2020
The biomarkes NT-proBNP, ST2 and Pentraxin-3 (Ptx-3) have emerged as potential powerful tools in stratifying the risk of unfavorable cardiovascular events in cardiac patients in post-MI period. Goal was to investigate the potential prognostic power of the biomarkers ST2, Ptx-3 andNT-proBNP in cardiovascular events risk stratification in 2 years FU after STEMI.
Цитирование
